You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2024

CYKLOKAPRON Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Cyklokapron patents expire, and when can generic versions of Cyklokapron launch?

Cyklokapron is a drug marketed by Pfizer and Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in CYKLOKAPRON is tranexamic acid. There are eight drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the tranexamic acid profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cyklokapron

A generic version of CYKLOKAPRON was approved as tranexamic acid by AM REGENT on August 10th, 2011.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CYKLOKAPRON?
  • What are the global sales for CYKLOKAPRON?
  • What is Average Wholesale Price for CYKLOKAPRON?
Drug patent expirations by year for CYKLOKAPRON
Drug Prices for CYKLOKAPRON

See drug prices for CYKLOKAPRON

Recent Clinical Trials for CYKLOKAPRON

Identify potential brand extensions & 505(b)(2) entrants

Northwestern UniversityPhase 3
Karolinska InstitutetPhase 4
University of Cape TownPhase 4

See all CYKLOKAPRON clinical trials

Pharmacology for CYKLOKAPRON
Drug ClassAntifibrinolytic Agent
Physiological EffectDecreased Fibrinolysis

US Patents and Regulatory Information for CYKLOKAPRON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer CYKLOKAPRON tranexamic acid INJECTABLE;INJECTION 019281-001 Dec 30, 1986 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn CYKLOKAPRON tranexamic acid TABLET;ORAL 019280-001 Dec 30, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for CYKLOKAPRON

See the table below for patents covering CYKLOKAPRON around the world.

Country Patent Number Title Estimated Expiration
Germany 1443755 ⤷  Sign Up
Germany 1793841 trans-4-Aminomethylcyclohexan-1-carbonsaeure und Verfahren zur Herstellung ⤷  Sign Up
Belgium 657492 ⤷  Sign Up
United Kingdom 1094876 ⤷  Sign Up
Switzerland 444146 Verfahren zur Herstellung der trans-4-Aminomethyl-cyclohexan-1-carbonsäure ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.